The Mechanism of Checkpoint Inhibitors in Gynecologic Cancer

Abstract

Currently, immunomodulators are used in different cancer entities, including gynecologic malignancies. Toxicity is variable but of narrow extent. Among immunomodulators, checkpoint inhibitors are used to enhance the immune system and significantly improve therapeutic results of advanced disease, mounting tumor progression.